Navigation Links
MiddleBrook Pharmaceuticals Reports Second Quarter 2008 Results
Date:8/14/2008

ld Management in the fourth quarter of 2007. The Company recorded a $7.4 million noncash warrant expense in the first quarter of 2008. There were no such gains or expenses in the second quarter of 2007.

-- Net loss for the second quarter of 2008 was $3.7 million. This compares to a net loss of $13.8 million in the first quarter of 2008, and $9.5 million in the second quarter of 2007. The net loss for the three months ended June 30, 2008, was increased by $0.1 million attributable to the gain from noncontrolling interest in two companies affiliated with Deerfield Management pursuant to the fourth quarter 2007 Keflex transaction, resulting from MiddleBrook's consolidation of the two affiliates under Financial Accounting Standards Board Interpretation No. 46 (revised 2003) "Consolidation of Variable Interest Entities." The net loss for the three months ended March 31, 2008, was reduced by $0.2 million attributable to the loss from noncontrolling interest during that quarter and there were no such gains or losses for the second quarter of 2007.

-- Net loss per share applicable to common stockholders for the second quarter of 2008 was ($0.07), compared to a loss per common share of ($0.26) in the prior quarter and ($0.21) in the second quarter of 2007.

Per share figures were computed on the basis of an average of 56.0 million shares outstanding in the second quarter of 2008, 53.3 million shares outstanding in the first quarter of 2008, and 45.3 million shares outstanding in the second quarter of 2007.

-- Cash and marketable securities decreased by $5.4 million during the second quarter. Changes were composed of $5.4 million of operating losses in the quarter, and $1.4 million for working capital changes and other items; offset by $1.2 million for non-cash expenses in the quarter and $0.2 million from the exercise of stock options.

-- The Balance Sheet at June 30, 2008 reflected $12.6 million of unrestricted cash, cash equivalents and ma
'/>"/>

SOURCE MiddleBrook Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results
2. MiddleBrook Pharmaceuticals Engages Morgan Stanley in Its Strategic Process
3. MiddleBrook Pharmaceuticals to Raise $21 Million Through Private Placement of Common Equity
4. MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results
5. MiddleBrook Pharmaceuticals Raises Up to $10 Million from Deerfield Management
6. Alseres Pharmaceuticals, Inc. Reports Second Quarter 2008 Operational and Financial Results
7. Lotus Pharmaceuticals Announces Conference Call to Discuss Second Quarter 2008 Results
8. MAP Pharmaceuticals Reports Second Quarter of 2008 Financial Results
9. Triax Pharmaceuticals Launches New Mid-Potency Corticosteroid Vehicle, Locoid Lotion 0.1%
10. ADVENTRX Pharmaceuticals Reports Second Quarter 2008 Financial Results and Business Update
11. Novis Pharmaceuticals Announces John W. Kilgour as Executive Vice-President of Sales & Marketing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2014)... Parents and physicians concerned about an increase in ... can breathe a sigh of relief. According to a ... years worth of data from states with and without ... to increased use among adolescents. The study is published ... of Adolescent Health . , "Any time a ...
(Date:4/23/2014)... that proliferation of endogenous neural precursor cells cannot ... axons. From the perspective of neural plasticity, Dr. ... in China observed the effects of functional electrical ... and expression of basic fibroblast growth factor and ... the infarct side. The researchers found that functional ...
(Date:4/22/2014)... FDA-approved device has been shown to reduce seizures in ... percent. When coupled with an innovative electrode placement planning ... the complete elimination of seizures in nearly half of ... trials. , That,s good news for a large portion ... with epilepsy whose seizures can,t be controlled with medications ...
(Date:4/22/2014)... 15 percent of all lung cancers are small ... often develop resistance to chemotherapy. However, researchers at ... new insights into the mechanisms leading to this ... , Chemotherapies work primarily by mediating B-cell lymphoma ... regulating cell death. Depending on their function, this ...
(Date:4/22/2014)... mice and rabbits, Johns Hopkins scientists have found a ... successfully preventing the development of atherosclerosis, the main cause ... of death among humans. The condition develops when fat ... stiff, narrowed and hardened, greatly reducing their ability to ... brain. , In a series of experiments, described April ...
Breaking Medicine News(10 mins):Health News:RI Hospital physician: Legalizing medical marijuana doesn't increase use among adolescents 2Health News:Newly approved brain stimulator offers hope for individuals with uncontrolled epilepsy 2Health News:Scientists pinpoint protein that could improve small cell lung cancer therapies 2Health News:Scientists alter fat metabolism in animals to prevent most common type of heart disease 2Health News:Scientists alter fat metabolism in animals to prevent most common type of heart disease 3Health News:Scientists alter fat metabolism in animals to prevent most common type of heart disease 4
... Community Unites Behind Extraordinary Global Effort, ... SAN FRANCISCO, July 23 The Medpedia ... largest collaborative online,encyclopedia of medicine called Medpedia. ... health professionals are now,volunteering to collaboratively build ...
... treatment and prognosis may be affected, study says , , ... or pancreatic cancer may have more lymph nodes examined ... designated comprehensive cancer centers or at hospitals that do ... study. , If too few lymph nodes are examined ...
... international scientific and professional organization of more than ... technology and science of molecular imaging and nuclear ... nuclear medicine and molecular imaging research. The awards, ... announced at SNM,s 55th Annual Meeting, held in ...
... program saves time, reduces costs and increases safety; $1000 incentive may ... ... Chapel Hill, NC (PRWEB) July 22, 2008 -- Imagine a health ... prescription into a PDA or computer, and getting immediate feedback about ...
... head and neck cancer, accurately determining how advanced the cancer ... until now. New Saint Louis University research has found ... tool to detect secondary cancers, which occur in 5 to ... study findings, which will be presented on Tuesday, July 22 ...
... body, they could lead to nonsurgical treatments , , TUESDAY, July ... valuable in efforts to develop nonsurgical treatments for spinal cord ... and Sweden. , They say it may be possible to ... to repair damaged nerve cells. , An adult,s spinal cord ...
Cached Medicine News:Health News:Medpedia Announced, World's Largest Collaborative Online Encyclopedia of Medicine and Health 2Health News:Medpedia Announced, World's Largest Collaborative Online Encyclopedia of Medicine and Health 3Health News:Medpedia Announced, World's Largest Collaborative Online Encyclopedia of Medicine and Health 4Health News:Medpedia Announced, World's Largest Collaborative Online Encyclopedia of Medicine and Health 5Health News:Medpedia Announced, World's Largest Collaborative Online Encyclopedia of Medicine and Health 6Health News:Medpedia Announced, World's Largest Collaborative Online Encyclopedia of Medicine and Health 7Health News:Medpedia Announced, World's Largest Collaborative Online Encyclopedia of Medicine and Health 8Health News:More Cancer Lymph Nodes Analyzed at Specialty Centers 2Health News:Seeding the future: SNM grants grow molecular imaging and nuclear medicine research 2Health News:Seeding the future: SNM grants grow molecular imaging and nuclear medicine research 3Health News:BCBSNC Makes Electronic Prescribing Available Statewide 2Health News:BCBSNC Makes Electronic Prescribing Available Statewide 3Health News:BCBSNC Makes Electronic Prescribing Available Statewide 4Health News:Has cancer spread? Research identifies best way to find answers so treatment can begin 2Health News:Spinal Cord Stem Cells May Act as Nerve Repair System 2
(Date:1/14/2014)... 2014 Animal Emergency Critical Care, a LifeCentre partner practice, located ... is the first in Loudoun County ... Dr. Susan M. Barnes , Medical Director, is a well-seasoned ... Cole Taylor , are avid scuba divers. "As altitude skiers ...
(Date:1/14/2014)... 14, 2014 NineSigma , Inc., the leading ... Innovation Leadership Summit , May 14-16, 2014 at the ... Ohio . This is the ... to breakthrough achievements through open innovation. Participants will learn ...
(Date:1/14/2014)... , January 14, 2014 ... Transfer Devices (CSTD) for hazardous drugs, today announced that it ... fourth straight year.   Equashield,s closed ... technicians, pharmacists, nurses and other medical professionals who ...
Breaking Medicine Technology:Hyperbaric Veterinary Medicine (hvm) Announces Animal Emergency Critical Care Installs A Small Animal Hyperbaric Chamber 2Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 2Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 3Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 4Equashield's Sales Grow by 60% in 2013 2
...  Merrimack Pharmaceuticals, Inc. announced today that the first ... clinical study combining MM-121, a fully human monoclonal ... irinotecan (Camptosar®) in patients with advanced cancers. ... The Phase 1 study evaluates the safety and ...
... Md., Dec. 13, 2011 The U.S. Food and ... device intended to aid in the detection of life-threatening ... spectroscopy. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... health care providers identify patients with critical head injuries ...
Cached Medicine Technology:Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Study of MM-121 in Combination with Cetuximab and Irinotecan in Patients with Advanced Cancers 2FDA Permits Marketing of the First Hand-Held Device To Aid in the Detection of Bleeding In The Skull 2FDA Permits Marketing of the First Hand-Held Device To Aid in the Detection of Bleeding In The Skull 3
Optimal solution for normal acetabulum....
The Biopro Cox comb cup is manufactured from titanium and is porous coated on the outside of the shell. The Cox comb cup accommodates a polyethylene insert....
The Plasmacup SC satisfies two important requirements: high primary stability and a low friction bearing surface....
... The integration of Trabecular Metal ... proven implant design results in a ... not only meets surgeon demands for ... provides a wide variety of shell ...
Medicine Products: